Cochrane Abstracts
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fixed Dose Subcutaneous Low Molecular Weight Heparins Versus Adjusted Dose Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431752/1/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/1/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed April 29, 2025.
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/1/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Fixed Dose Subcutaneous Low Molecular Weight Heparins Versus Adjusted Dose Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/1/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
ID - 431752
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/1/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism_New_search_for_studies_and_content_updated__no_change_to_conclusions_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
